Notably, previous MR analyses investigating the effects of ACLY inhibition used a genetic instrument that was not robustly associated with LDL-c and further considered T2DM risk as an outcome but not other related glycaemic or anthropometric traits [19,20,21]. Here, ACLY is linked to type 2 diabetes mellitus.